Standard Operating Procedure for Final Approval of Health Authority Response Packages
| Department | Regulatory Affairs |
| SOP No. | RA/2026/742 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 15/04/2026 |
| Effective Date | 15/04/2026 |
| Review Date | 15/04/2028 |
Purpose
This Standard Operating Procedure (SOP) outlines the process for the final review and approval of response packages prepared for health authority queries and deficiency letters. The purpose is to ensure that all submissions to regulatory authorities are complete, accurate, compliant with regulatory requirements, and internally authorized prior to submission. This control objective supports regulatory compliance, minimizes risks of rejection or delays, and maintains the integrity of communication with health authorities.
Scope
This SOP applies to all regulatory affairs personnel involved in preparing, reviewing, and approving responses to health authority queries or deficiency letters related to any pharmaceutical product, dosage form, or submission type. It covers compilation, quality checks, internal evaluations, final approval, and documentation of response packages. This SOP excludes activities related to initial submission preparation or non-regulatory correspondence.
Responsibilities
– Regulatory Affairs Associate: Prepare response packages based on queries.
– Regulatory Affairs Reviewer: Review and verify the technical content and compliance.
– Quality Assurance Department: Review for compliance with internal standards and regulatory guidelines.
– Regulatory Affairs Head: Approve the final response package prior to submission.
– Document Control: Archive finalized response packages and related records.
Accountability
The Head of Regulatory Affairs is accountable for the implementation, compliance, periodic review, and continuous improvement of this SOP. This role ensures timely escalation of issues, monitors effectiveness, and authorizes any amendments or deviations.
Procedure
The final approval of health authority response packages shall be conducted as follows:
1. Preparation: Upon receipt of a health authority query or deficiency letter, the Regulatory Affairs Associate compiles the required information and draft responses, ensuring all supporting documents are included. A cross-departmental input may be gathered if needed.
2. Preliminary Review: The prepared draft response package undergoes an initial technical review by a Regulatory Affairs Reviewer for accuracy, completeness, and regulatory compliance. Any comments or amendments are addressed by the preparer.
3. Quality Assurance Review: The package is forwarded to Quality Assurance for an independent review focused on compliance with internal SOPs, formatting standards, and regulatory expectations. QA must verify document control identifiers and integrity of records.
4. Final Approval: The package, post QA clearance, is submitted to the Regulatory Affairs Head for final approval. The approver verifies that all comments are resolved, the response is complete, and ready for submission. No changes should be made after final approval.
5. Documentation and Record Keeping: Once approved, the final response package is documented in the regulatory tracking system. Copies are archived electronically and physically as per data retention policies to ensure traceability.
6. Submission: The approved package is submitted to the relevant health authority within the stipulated timelines. Confirmation of receipt and any relevant correspondence must be recorded.
7. Deviation Handling: Any deviations from this procedure, such as timeline exceptions or content disputes, must be documented and escalated to the Regulatory Affairs Head for resolution and CAPA initiation if necessary.
8. Periodic Review: This SOP and related processes shall be periodically reviewed and updated to incorporate changes in regulatory requirements or organizational policies.
Throughout all stages, adherence to Good Documentation Practices (GDP) and Good Regulatory Practices (GRP) shall be ensured. All personnel involved must sign or electronically approve steps per organizational policy to maintain an audit trail.
Abbreviations
HA – Health Authority
RA – Regulatory Affairs
QA – Quality Assurance
SOP – Standard Operating Procedure
CAPA – Corrective and Preventive Action
GDP – Good Documentation Practices
GRP – Good Regulatory Practices
Documents
The following documents are essential for implementation of this SOP:
- Health Authority Response Package Template (Annexure-1)
- Final Approval Checklist for Health Authority Response (Annexure-2)
- Regulatory Submission Record Log (Annexure-3)
References
– ICH Q10 – Pharmaceutical Quality System
– FDA Guidance for Industry: Responding to Inspectional Observations
– EU GMP Chapter 4 – Documentation
– WHO Technical Report Series – Good Regulatory Practices
– Internal Quality Management System Documentation
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Health Authority Response Package Template
Purpose: To provide a standardized format for preparing comprehensive response packages to health authority queries and deficiency letters.
| Field | Details / Example |
|---|---|
| Health Authority Name | Medicines Regulatory Agency |
| Query Reference Number | HAQ-2026-0472 |
| Product Name | Product X 20mg Tablets |
| Submission Type | Marketing Authorization Application |
| Date of Query Receipt | 03/04/2026 |
| Response Due Date | 24/04/2026 |
| Summary of Queries | Clarification on stability data and batch release criteria. |
| Proposed Response | Detailed stability report attached; batch release criteria documented per SOP QA-045. |
| Supporting Documents | Stability Study Report (Ref: STR-2026-09), Batch Release Records (BRR-2025-11) |
| Prepared By | Regulatory Affairs Associate – Date: 10/04/2026 |
| Reviewed By | Regulatory Affairs Reviewer – Date: 12/04/2026 |
| Quality Assurance Review | QA Department – Date: 13/04/2026 |
| Final Approval | Regulatory Affairs Head – Date: 14/04/2026 |
Annexure-2: Final Approval Checklist for Health Authority Response
Purpose: To verify completeness, accuracy, and compliance of response packages prior to final approval and submission.
| Checklist Item | Yes / No | Comments |
|---|---|---|
| All queries addressed satisfactorily | Yes | – |
| Supporting documents attached and referenced | Yes | – |
| No unresolved comments from reviewers | Yes | – |
| Compliance with regulatory requirements confirmed | Yes | – |
| Document control identifiers correct | Yes | – |
| Submission timeline met | Yes | – |
| Final package signed and dated | Yes | – |
| Remarks | All criteria met; package ready for submission. | |
| Approver Signature | ||
| Date | 14/04/2026 | |
Annexure-3: Regulatory Submission Record Log
Purpose: To maintain a controlled record of all health authority response submissions including dates, reference numbers, and responsible persons.
| Entry No. | Query Reference Number | Product | Submission Date | Method of Submission | Submitted By | Remarks |
|---|---|---|---|---|---|---|
| 1 | HAQ-2026-0472 | Product X 20mg Tablets | 15/04/2026 | eCTD Portal | Regulatory Affairs | Submission successful, confirmation received. |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 15/04/2026 | 1.0 | Initial issue | New SOP creation |